Key result
Atrial cardiomyopathy is linked to ~79% higher cerebral small vessel disease burden in acute ischemic stroke.
Why the study?
Atrial cardiomyopathy and cerebral small vessel disease share common risk factors and mechanisms, but their relationship in acute ischemic stroke patients is unclear.
Does atrial cardiomyopathy correlate with increased total burden of cerebral small vessel disease in patients with acute ischemic stroke?
Observational (n=323)
No
Does atrial cardiomyopathy correlate with increased total burden of cerebral small vessel disease in patients with acute ischemic stroke?
Atrial cardiomyopathy, defined by PTFV1 > 5,000 μV·ms, is independently associated with a higher total burden of cerebral small vessel disease in patients with acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
Should not yet change stroke evaluation; leaves open whether atrial cardiomyopathy independently drives small vessel disease burden.
Background Atrial cardiomyopathy (ACM) and cerebral small vessel disease (CSVD) share common risk factors (e.g., hypertension, diabetes, dyslipidemia, aging) and pathophysiological mechanisms (e.g., inflammatory response, oxidative stress). Objective This study aimed to investigate the relationship between ACM and the total CSVD burden in patients with acute ischemic stroke (AIS). Methods We retrospectively enrolled eligible hospitalized AIS patients. Imaging markers were measured based on MRI data, including periventricular and deep white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), lacunes, cerebral microbleeds (CMBs), and brain atrophy. The total CSVD burden was calculated using the Wardlaw score. A P-wave terminal force in lead V1 (PTFV1) > 5,000 μV·ms was used to define atrial cardiomegaly (ACM), and a PTFV1 ≤ 5,000 μV·ms was adopted to define non-atrial cardiomegaly (NACM). Univariate and multivariate ordinal logistic regression analyses estimated the correlation between ACM and total CSVD burden. Results Among 323 enrolled patients (mean age 67.67 years, 63.7% male), 83 were classified as ACM. Patients with ACM had significantly higher total Wardlaw scores (OR = 1.79, 95% CI = 1.07–3.02, p = 0.026). Age, hypertension, and NIHSS score were also independent risk factors for increased total burden [OR = 1.05 (95% CI = 1.02–1.07, p < 0.001), 2.09 (95% CI = 1.29–3.42, p = 0.003), and 1.13 (95% CI = 1.03–1.24, p = 0.009), respectively]. Conclusion This study found a suggestive association between ACM and total CSVD burden in AIS patients, underscoring the importance of assessing ACM for evaluating CSVD risk factors in this patient population.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted an observational in Acute ischemic stroke (n=323). Atrial cardiomyopathy (ACM) vs. Non-atrial cardiomegaly (NACM) was evaluated on Total cerebral small vessel disease (CSVD) burden (total Wardlaw score) (OR 1.79, 95% CI 1.07-3.02, p=0.026). Atrial cardiomyopathy was associated with a higher total burden of cerebral small vessel disease in patients with acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: